| | | | | | Income statement | | | | | | Net sales | MEUR | 64,1 | 78,3 | 80,2 | | - change | % | -18,2 | -2,3 | -11,4 | | Operating profit/-loss | MEUR | -1,3 | 1,4 | -2,1 | | - of net sales, % | % | -2,1 | 1,8 | -2,6 | | Profit/loss before taxes | MEUR | -2,1 | 1,7 | -2,9 | | - of net sales, % | % | -3,3 | 2,2 | -3,6 | | Profit/loss for the period | MEUR | -2,6 | 1,2 | -3,4 | | - of net sales, % | % | -4,1 | 1,6 | -4,2 | | Gross investments | MEUR | 1,8 | 1,9 | 4,0 | | - of net sales, % | % | 2,7 | 2,5 | 4,9 | | | | | | | Balance sheet | | | | | | Non-current assets | MEUR | 8,0 | 9,9 | 11,4 | | Inventories | MEUR | 7,8 | 10,9 | 12,6 | | Trade receivables and other receivables | MEUR | 11,5 | 15,7 | 14,8 | | Tax Receivables, income tax | MEUR | 0,1 | 0,0 | 0,1 | | Cash and cash equivalents, financial assets at fair | MEUR | 5,4 | 5,1 | 7,7 | | value through profit and loss | | | | | | Share capital | MEUR | 34,5 | 34,5 | 34,5 | | Treasury shares | MEUR | -0,6 | 0,0 | 0,0 | | Other equity | MEUR | -14,3 | -9,5 | -7,4 | | Non-current liabilities | MEUR | 0,2 | 0,2 | 0,3 | | Current liabilities | MEUR | 13,0 | 16,5 | 19,4 | | Balance sheet total | MEUR | 32,7 | 41,7 | 46,7 | | | | | | | Profitability | | | | | | Return on equity (ROE) | % | -11,8 | 4,7 | -11,8 | | Return on investment (ROI) | % | -8,4 | 7,0 | -8,1 | | | | | | | Finance and financial position | | | | | | Net interest-bearing liabilities | MEUR | -4,9 | -4,0 | -6,6 | | Gearing | % | -25,3 | -16,0 | -24,6 | | Current ratio | | 1,9 | 1,9 | 1,8 | | Solvency ratio | % | 59,6 | 59,9 | 57,9 | | | | | | | Other key figures | | | | | | Personnel, average | | 565 | 637 | 766 | | Salaries and wages | MEUR | 10,7 | 11,9 | 13,2 | | | | | | | Product development costs (expensed) | MEUR | 6,9 | 6,6 | 5,1 | | - of net sales, % | | 10,7 | 8,5 | 6,3 | | Product development costs (capitalized in balance sheet) | MEUR | 0,7 | 0,5 | 0,9 | | - of net sales, % | | 1,1 | 0,7 | 1,2 | | Product development costs total | MEUR | 7,6 | 7,2 | 6,0 | | - of net sales, % | | 11,8 | 9,1 | 7,5 | | | | | | | | | | | | | IFRS | IFRS | IFRS | | KEY FINANCIAL INDICATORS PER SHARE | | 2009 | 2008 | 2007 | | | | | | | Earnings per share | EUR | -0,07 | 0,03 | -0,08 | | Diluted earnings per share | EUR | -0,07 | 0,03 | -0,08 | | Dividend/share | EUR | 0* | 0,04 | 0,10 | | Dividend payout ratio | % | 0,0 | 131,6 | -119,7 | | Effective dividend yield | % | 0,0 | 5,3 | 8,3 | | | | | | | Equity per share, adjusted | EUR | 0,49 | 0,62 | 0,67 | | At the end of fiscal year, October 31 | EUR | 0,85 | 0,76 | 1,20 | | P/E ratio | | -12,97 | 25,00 | -14,40 | | | | | | | Market value | | | | | | Market capitalization | MEUR | 33,7 | 30,8 | 48,6 | | | | | | | Trading | | | | | | Shares traded | 1 000 psc | 8 803 | 8 660 | 17 270 | | Trading, % | % | 21,7 | 21,4 | 42,6 | | | | | | | Number of shares adjusted | | | | | | - average | 1 000 pcs | 40 138 | 40 530 | 40 530 | | - diluted number of shares on October 31 | 1 000 pcs | 40 138 | 40 530 | 40 530 | | - actual number of shares on October 31 | 1 000 pcs | 40 138 | 40 530 | 40 530 | | - shares outstanding per October 31, 2009 | 1 000 pcs | 39 607 | 40 530 | 40 530 | | | | | | | Adjusted share prices | | | | | | lowest | EUR | 0,55 | 0,70 | 0,98 | | highest | EUR | 1,10 | 1,25 | 1,55 | | at the end of fiscal year | EUR | 0,85 | 0,76 | 1,20 | | average | EUR | 0,72 | 1,01 | 1,25 | | | | | | | * The board of Directors will propose for the Annual General Meeting on February 9, 2010 that no dividend will be distributed. |
|
|
|
